AI Engines For more Details: Perplexity Kagi Labs You
Antiparasitic Effects: Fenbendazole is highly effective against a wide range of parasitic infections in animals, including nematodes (roundworms), cestodes (tapeworms), and trematodes (flukes). It works by disrupting the microtubule structure in the parasites, leading to paralysis and death.
Treatment of Intestinal Parasites: Fenbendazole is commonly used to treat gastrointestinal parasites such as roundworms, hookworms, whipworms, and tapeworms in dogs, cats, horses, livestock, and other animals. It helps eliminate the parasites from the intestines, thereby reducing symptoms such as diarrhea, vomiting, weight loss, and abdominal discomfort.
Liver Fluke Infections: Fenbendazole is effective against liver fluke infections, including Fasciola hepatica and Fasciola gigantica, which can affect livestock such as cattle, sheep, and goats. By killing the immature and adult flukes, fenbendazole helps control the spread of these parasitic infections and prevent liver damage in animals.
Lungworm Infections: Fenbendazole is also used to treat lungworm infections in animals, including Metastrongylus spp. in pigs and Dictyocaulus spp. in cattle, sheep, and goats. It helps eliminate the lungworm larvae and adults from the respiratory tract, reducing respiratory symptoms and improving lung function.
Protozoal Infections: In addition to parasitic worms, fenbendazole may have activity against certain protozoal infections in animals, although its efficacy varies depending on the specific parasite species. It is sometimes used off-label for the treatment of protozoal infections such as Giardia and coccidiosis in animals.
Potential Anticancer Effects: There is growing interest in the potential anticancer effects of fenbendazole in humans. Some studies and anecdotal reports suggest that fenbendazole, when used in combination with other drugs or supplements, may inhibit cancer cell growth, induce apoptosis (cell death), and suppress tumor progression. However, more research is needed to fully understand its mechanisms of action and efficacy in cancer treatment.
Safety Considerations: Fenbendazole is generally well-tolerated in animals when used at recommended doses. However, adverse effects such as vomiting, diarrhea, lethargy, and allergic reactions may occur in some cases. It is important to follow dosage instructions carefully and consult a veterinarian before administering fenbendazole to animals, especially pregnant or lactating animals and those with pre-existing health conditions.
Drug Interactions: Fenbendazole may interact with certain medications or supplements in animals, potentially affecting their efficacy or safety. It is important to inform the veterinarian about all medications, supplements, and health conditions of the animal before starting fenbendazole treatment.
Resistance: Prolonged or repeated use of fenbendazole in animals may lead to the development of drug-resistant parasites. To minimize the risk of resistance, fenbendazole should be used judiciously and as part of a comprehensive parasite control program that includes proper hygiene, sanitation, and rotation of anthelmintic drugs.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lactobacillus acidophilus | Reduces |
species | Lactobacillus crispatus | Reduces |
species | Lactobacillus gasseri | Reduces |
species | Lactobacillus helveticus | Reduces |
species | Lactobacillus jensenii | Reduces |
species | Lactobacillus johnsonii | Reduces |
species | Lactobacillus kefiranofaciens | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Terrabacteria group | clade | Decreases |
0 | 1 | PVC group | clade | Increases |
0 | 1 | Actinomycetes | class | Decreases |
0 | 1 | Nitriliruptoria | class | Decreases |
0 | 1 | Coriobacteriia | class | Decreases |
0 | 1 | Acidimicrobiia | class | Decreases |
0 | 1 | Rubrobacteria | class | Decreases |
0 | 1 | Thermoleophilia | class | Decreases |
0 | 1 | Opitutia | class | Increases |
0 | 1 | Methylacidiphilae | class | Increases |
0 | 1 | Spartobacteria | class | Increases |
0 | 1 | Terrimicrobiia | class | Increases |
0 | 1 | Verrucomicrobiia | class | Increases |
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Lactobacillaceae | family | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
1 | 0 | Lactobacillus | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | unclassified Actinomycetota | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | unclassified Lactobacillus | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Increases |
0 | 1 | unclassified Verrucomicrobiota | no rank | Increases |
0 | 1 | Verrucomicrobiota incertae sedis | no rank | Increases |
1 | 0 | Actinomycetota | phylum | Decreases |
1 | 0 | Verrucomicrobiota | phylum | Increases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
0 | 1 | Lactobacillus delbrueckii | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
0 | 1 | [Lactobacillus] rogosae | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | ATCC 15434 | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | Lactobacillus alvei | species | Decreases |
0 | 1 | Lactobacillus animata | species | Decreases |
0 | 1 | Lactobacillus apis | species | Decreases |
0 | 1 | Lactobacillus bombicola | species | Decreases |
0 | 1 | Lactobacillus brevisimilis | species | Decreases |
0 | 1 | Lactobacillus equicursoris | species | Decreases |
0 | 1 | Lactobacillus faeni | species | Decreases |
0 | 1 | Lactobacillus fornicalis | species | Decreases |
0 | 1 | Lactobacillus gallinarum | species | Decreases |
0 | 1 | Lactobacillus gigeriorum | species | Decreases |
0 | 1 | Lactobacillus guizhouensis | species | Decreases |
0 | 1 | Lactobacillus hamsteri | species | Decreases |
0 | 1 | Lactobacillus helsingborgensis | species | Decreases |
0 | 1 | Lactobacillus hominis | species | Decreases |
0 | 1 | Lactobacillus intermedius | species | Decreases |
0 | 1 | Lactobacillus japonicus | species | Decreases |
0 | 1 | Lactobacillus kalixensis | species | Decreases |
0 | 1 | Lactobacillus kitasatonis | species | Decreases |
0 | 1 | Lactobacillus kullabergensis | species | Decreases |
0 | 1 | Lactobacillus leichmannii | species | Decreases |
0 | 1 | Lactobacillus letivazi | species | Decreases |
0 | 1 | Lactobacillus mulieris | species | Decreases |
0 | 1 | Lactobacillus panisapium | species | Decreases |
0 | 1 | Lactobacillus pasteurii | species | Decreases |
0 | 1 | Lactobacillus psittaci | species | Decreases |
0 | 1 | Lactobacillus rodentium | species | Decreases |
0 | 1 | Lactobacillus selangorensis | species | Decreases |
0 | 1 | Lactobacillus sp. 7_1_47FAA | species | Decreases |
0 | 1 | Lactobacillus sp. MYMRS/TEN2 | species | Decreases |
0 | 1 | Lactobacillus terrae | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Lactobacillus gasseri | species | Decreases |
0 | 1 | Lactobacillus jensenii | species | Decreases |
0 | 1 | Lactobacillus paragasseri | species | Decreases |
0 | 1 | Lactobacillus acidophilus | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Lactobacillus intestinalis | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
0 | 1 | Lactobacillus crispatus | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Lactobacillus taiwanensis | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
0 | 1 | Lactobacillus iners | species | Decreases |
0 | 1 | Lactobacillus amylovorus | species | Decreases |
0 | 1 | Lactobacillus acetotolerans | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
0 | 1 | Lactobacillus amylolyticus | species | Decreases |
0 | 1 | Lactobacillus kefiranofaciens | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Lactobacillus johnsonii | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
0 | 1 | Lactobacillus helveticus | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Lactobacillus ultunensis | species | Decreases |
0 | 1 | Lactobacillus casei group | species group | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.6 | |
Acne | 0.6 | 2 | -2.33 |
ADHD | 3.5 | 1.9 | 0.84 |
Age-Related Macular Degeneration and Glaucoma | 1.1 | 0.4 | 1.75 |
Allergic Rhinitis (Hay Fever) | 2.8 | 3.1 | -0.11 |
Allergies | 5.6 | 3.2 | 0.75 |
Allergy to milk products | 1.9 | 1.6 | 0.19 |
Alopecia (Hair Loss) | 1 | 1 | |
Alzheimer's disease | 6.4 | 6.6 | -0.03 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 4 | 0.5 | 7 |
Ankylosing spondylitis | 4.8 | 2.5 | 0.92 |
Anorexia Nervosa | 1.8 | 2.5 | -0.39 |
Antiphospholipid syndrome (APS) | 1.6 | 1.6 | |
Asthma | 5.1 | 3.6 | 0.42 |
Atherosclerosis | 2.1 | 1.9 | 0.11 |
Atrial fibrillation | 3.9 | 1.9 | 1.05 |
Autism | 9.4 | 7.9 | 0.19 |
Autoimmune Disease | 1.7 | 1.6 | 0.06 |
Barrett esophagus cancer | 0.3 | -0.3 | |
benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
Biofilm | 0.6 | 0.6 | |
Bipolar Disorder | 2.9 | 1.1 | 1.64 |
Brain Trauma | 0.6 | 1.6 | -1.67 |
Breast Cancer | 0.6 | 0.6 | |
Cancer (General) | 2.1 | -2.1 | |
Carcinoma | 2.9 | 1.7 | 0.71 |
Celiac Disease | 2.5 | 3.3 | -0.32 |
Cerebral Palsy | 1.3 | 1 | 0.3 |
Chronic Fatigue Syndrome | 2.1 | 4.5 | -1.14 |
Chronic Kidney Disease | 3 | 2.8 | 0.07 |
Chronic Lyme | 0 | 0.8 | 0 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.4 | 1.4 | 0.71 |
Chronic Urticaria (Hives) | 2.2 | 1.1 | 1 |
Coagulation / Micro clot triggering bacteria | 1.4 | 1 | 0.4 |
Cognitive Function | 3.2 | 2 | 0.6 |
Colorectal Cancer | 7.7 | 3.3 | 1.33 |
Constipation | 1.5 | 0.9 | 0.67 |
Coronary artery disease | 1.3 | 2.5 | -0.92 |
COVID-19 | 7.9 | 9.4 | -0.19 |
Crohn's Disease | 6.4 | 5.3 | 0.21 |
Cushing's Syndrome (hypercortisolism) | 0.6 | -0.6 | |
cystic fibrosis | 1.2 | 1.6 | -0.33 |
d-lactic acidosis (one form of brain fog) | 1 | 1 | |
deep vein thrombosis | 2.4 | 1.1 | 1.18 |
Denture Wearers Oral Shifts | 0.9 | 0.5 | 0.8 |
Depression | 8.7 | 9.3 | -0.07 |
Dermatomyositis | 0.3 | 0.3 | 0 |
Eczema | 1.1 | 2.3 | -1.09 |
Endometriosis | 4 | 2.6 | 0.54 |
Eosinophilic Esophagitis | 0.3 | -0.3 | |
Epilepsy | 3.5 | 3.5 | 0 |
erectile dysfunction | 1.1 | 0.3 | 2.67 |
Fibromyalgia | 3 | 2 | 0.5 |
Functional constipation / chronic idiopathic constipation | 4.3 | 4.2 | 0.02 |
gallstone disease (gsd) | 2.7 | 1.6 | 0.69 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.8 | 1.4 | -0.75 |
Generalized anxiety disorder | 2.7 | 2.2 | 0.23 |
giant cell arteritis | 0.2 | -0.2 | |
Glioblastoma | 0.3 | -0.3 | |
Gout | 1 | 0.7 | 0.43 |
Graves' disease | 2.8 | 2.9 | -0.04 |
Gulf War Syndrome | 1.4 | 2.1 | -0.5 |
Halitosis | 0.6 | 0.3 | 1 |
Hashimoto's thyroiditis | 3.7 | 2.4 | 0.54 |
Heart Failure | 3.7 | 2.4 | 0.54 |
hemorrhagic stroke | 1 | 0.5 | 1 |
Hidradenitis Suppurativa | 0.9 | 0.9 | |
High Histamine/low DAO | 1.9 | 0.3 | 5.33 |
hypercholesterolemia (High Cholesterol) | 0.3 | 0.5 | -0.67 |
hyperglycemia | 1.9 | 2.4 | -0.26 |
Hyperlipidemia (High Blood Fats) | 1 | 1.9 | -0.9 |
hypersomnia | 0.3 | -0.3 | |
hypertension (High Blood Pressure | 5.2 | 5.1 | 0.02 |
Hypothyroidism | 0.8 | 1.5 | -0.88 |
Hypoxia | 3.8 | 0.9 | 3.22 |
IgA nephropathy (IgAN) | 1.5 | 3 | -1 |
Inflammatory Bowel Disease | 7.3 | 7.8 | -0.07 |
Insomnia | 3.9 | 2.7 | 0.44 |
Intelligence | 1 | 0.1 | 9 |
Intracranial aneurysms | 0.9 | 1.1 | -0.22 |
Irritable Bowel Syndrome | 7.2 | 5.5 | 0.31 |
ischemic stroke | 2.8 | 1.7 | 0.65 |
Juvenile idiopathic arthritis | 0.5 | 0.5 | |
Liver Cirrhosis | 7.2 | 5 | 0.44 |
Long COVID | 7.3 | 6.7 | 0.09 |
Low bone mineral density | 1.1 | -1.1 | |
Lung Cancer | 0.8 | 1.2 | -0.5 |
Lymphoma | 0.6 | 0.6 | |
Mast Cell Issues / mastitis | 0.9 | 1.1 | -0.22 |
ME/CFS with IBS | 0.5 | 2.1 | -3.2 |
ME/CFS without IBS | 1 | 1.8 | -0.8 |
membranous nephropathy | 0.3 | 0.3 | |
Menopause | 0.8 | 1.4 | -0.75 |
Metabolic Syndrome | 6.7 | 6.5 | 0.03 |
Mood Disorders | 9.6 | 7.8 | 0.23 |
multiple chemical sensitivity [MCS] | 1.6 | 0.1 | 15 |
Multiple Sclerosis | 7.2 | 7.1 | 0.01 |
Multiple system atrophy (MSA) | 1.4 | 0.4 | 2.5 |
myasthenia gravis | 0.9 | 0.7 | 0.29 |
neuropathic pain | 0.3 | 2.2 | -6.33 |
Neuropathy (all types) | 1.5 | 2.2 | -0.47 |
neuropsychiatric disorders (PANDAS, PANS) | 0.4 | 0.4 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.4 | 4.2 | 0.05 |
NonCeliac Gluten Sensitivity | 2 | 1.7 | 0.18 |
Obesity | 9.4 | 8.1 | 0.16 |
obsessive-compulsive disorder | 4.1 | 3.9 | 0.05 |
Osteoarthritis | 1.7 | 1.6 | 0.06 |
Osteoporosis | 2.4 | 2.3 | 0.04 |
pancreatic cancer | 0.3 | 0.3 | 0 |
Parkinson's Disease | 8.9 | 7.6 | 0.17 |
Polycystic ovary syndrome | 5.7 | 2.5 | 1.28 |
Postural orthostatic tachycardia syndrome | 0.2 | 0.6 | -2 |
Premenstrual dysphoric disorder | 0.4 | 0.4 | 0 |
primary biliary cholangitis | 1.6 | 0.6 | 1.67 |
Primary sclerosing cholangitis | 1.9 | 1.9 | 0 |
Psoriasis | 4.9 | 2.6 | 0.88 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 7.1 | 4.3 | 0.65 |
Rosacea | 1.9 | 1.5 | 0.27 |
Schizophrenia | 6 | 4.4 | 0.36 |
scoliosis | 0.4 | 0.5 | -0.25 |
Sjögren syndrome | 1.8 | 3.5 | -0.94 |
Sleep Apnea | 2.1 | 2.6 | -0.24 |
Slow gastric motility / Gastroparesis | 0.4 | 0.8 | -1 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.6 | 0.1 | 15 |
Stress / posttraumatic stress disorder | 3.7 | 4.2 | -0.14 |
Systemic Lupus Erythematosus | 4.2 | 3 | 0.4 |
Tic Disorder | 0.6 | 1 | -0.67 |
Tourette syndrome | 1.1 | 0.8 | 0.38 |
Type 1 Diabetes | 4.2 | 4 | 0.05 |
Type 2 Diabetes | 7.9 | 8.2 | -0.04 |
Ulcerative colitis | 6.9 | 5.5 | 0.25 |
Unhealthy Ageing | 3.7 | 2.6 | 0.42 |
Vitiligo | 2.1 | 1.7 | 0.24 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]